HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maki Etori Selected Research

2- (4- (2- (diethylamino)ethoxy)phenyl)- N- (2,4- difluorobenzyl)- 5- fluoropyrimidin- 4- amine

1/2010RS-1748, a novel CC chemokine receptor 4 antagonist, inhibits ovalbumin-induced airway inflammation in guinea pigs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maki Etori Research Topics

Disease

3Inflammation (Inflammations)
07/2012 - 08/2005
2Atopic Dermatitis (Atopic Eczema)
10/2010 - 12/2009
1Necrosis
10/2010
1Shock
10/2010
1Asthma (Bronchial Asthma)
01/2010

Drug/Important Bio-Agent (IBA)

2AntigensIBA
07/2012 - 08/2005
2Immunoglobulin E (IgE)IBA
07/2012 - 08/2005
2CCR4 ReceptorsIBA
10/2010 - 01/2010
2OvalbuminIBA
10/2010 - 01/2010
1Melanocortin Receptors (Melanocortin Receptor)IBA
07/2012
1Melanocyte-Stimulating Hormones (MSH)IBA
07/2012
1LipopolysaccharidesIBA
10/2010
1RS-1269IBA
10/2010
12- (4- (2- (diethylamino)ethoxy)phenyl)- N- (2,4- difluorobenzyl)- 5- fluoropyrimidin- 4- amineIBA
01/2010
13- (2- (2- phenyl- 4- (4- pyridin- 4- ylbenzyl)morpholin- 2- yl)ethyl)quinazoline- 2,4(1H,3H)- dioneIBA
12/2009

Therapy/Procedure

1Oral Administration
10/2010